Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.05B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.61B |
| 3 |
Tesla
TSLA
|
+$636M |
| 4 |
TSMC
TSM
|
+$604M |
| 5 |
iShares Bitcoin Trust
IBIT
|
+$330M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.25B |
| 2 |
Apple
AAPL
|
+$1.13B |
| 3 |
Microsoft
MSFT
|
+$988M |
| 4 |
Meta Platforms (Facebook)
META
|
+$572M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$570M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 1.55% |
| 2 | Consumer Discretionary | 0.95% |
| 3 | Financials | 0.77% |
| 4 | Healthcare | 0.67% |
| 5 | Industrials | 0.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
826
PUT
Teva Pharmaceuticals
TEVA
$43B
| $70.8M | 0.01% |
4,604,400
+2,443,600
| +113% | +$43.6M |
|
|
SWTX
827
CALL
DELISTED
SpringWorks Therapeutics
SWTX
| $70.8M | 0.01% |
1,603,500
+1,585,600
| +8,858% | +$73M |
|
828
PUT
Allstate
ALL
$65.8B
| $70.4M | 0.01% |
339,800
+84,900
| +33% | +$16.5M |
|
829
Comcast
CMCSA
$95.9B
| $70.3M | 0.01% |
1,904,138
-592,714
| -24% | -$21.4M |
|
830
PUT
International Paper
IP
$21.7B
| $70.1M | 0.01% |
1,313,300
-20,700
| -2% | -$1.13M |
|
831
PUT
PG&E
PCG
$39.9B
| $69.9M | 0.01% |
4,071,400
+3,457,800
| +564% | +$57.4M |
|
832
PUT
General Dynamics
GD
$104B
| $69.9M | 0.01% |
256,500
-117,500
| -31% | -$30.5M |
|
833
PUT
NXP Semiconductors
NXPI
$56.1B
| $69.9M | 0.01% |
367,700
-85,900
| -19% | -$18.3M |
|
834
CALL
Mondelez International
MDLZ
$82.6B
| $69.8M | 0.01% |
1,028,700
-70,400
| -6% | -$4.34M |
|
835
Eli Lilly
LLY
$1.11T
| $69.7M | 0.01% |
84,340
-397,912
| -83% | -$331M |
|
836
PUT
2x Bitcoin ETF
BITX
$1.26B
| $69.6M | 0.01% |
1,960,600
-218,000
| -10% | -$10.7M |
|
837
CALL
MPLX
MPLX
$59.3B
| $69.5M | 0.01% |
1,298,400
+254,200
| +24% | +$13.3M |
|
838
CALL
e.l.f. Beauty
ELF
$6.25B
| $69.2M | 0.01% |
1,102,800
+195,300
| +22% | +$17M |
|
|
TEM
839
Tempus AI
TEM
$11.9B
| $69.2M | 0.01% |
1,434,550
+1,218,059
| +563% | +$65.8M |
|
840
CALL
EQT Corp
EQT
$33.6B
| $69.1M | 0.01% |
1,293,200
-1,006,600
| -44% | -$51.4M |
|
841
PUT
MetLife
MET
$61.1B
| $69.1M | 0.01% |
860,100
-48,600
| -5% | -$4.04M |
|
842
CALL
TotalEnergies
TTE
$198B
| $69.1M | 0.01% |
1,067,500
+421,000
| +65% | +$25.4M |
|
843
Petrobras
PBR
$120B
| $68.9M | 0.01% |
4,802,097
+633,658
| +15% | +$8.74M |
|
844
CALL
Alnylam Pharmaceuticals
ALNY
$31.6B
| $68.7M | 0.01% |
254,400
+60,300
| +31% | +$15.5M |
|
845
ExxonMobil
XOM
$675B
| $68.6M | 0.01% |
577,175
-2,069,406
| -78% | -$229M |
|
846
CALL
BHP
BHP
$247B
| $68.5M | 0.01% |
1,410,400
+294,900
| +26% | +$14.7M |
|
|
FLG
847
PUT
Flagstar Bank National Association
FLG
$5.57B
| $68.4M | 0.01% |
5,883,600
+425,400
| +8% | +$4.78M |
|
848
CALL
Brinker International
EAT
$10.9B
| $68.2M | 0.01% |
457,700
+89,000
| +24% | +$13.7M |
|
849
PUT
American Eagle Outfitters
AEO
$2.83B
| $68.1M | 0.01% |
5,859,500
+3,938,200
| +205% | +$56.3M |
|
850
PUT
Ferrari
RACE
$74.6B
| $68M | 0.01% |
159,000
-59,000
| -27% | -$26.5M |
|
Similar funds
Jeff Yass's Q1 2025 Portfolio in Review
As of Q1 2025, Jeff Yass held 13,842 positions worth $586B, down 12% from $663B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Jeff Yass withdrew a net $24.4B in Q1 2025, closing 1,483 positions and reducing 4,842 holdings. Its most notable exit was Inari Medical, Inc. Common Stock, an estimated $24M position sold in full.
By sector, the portfolio is most concentrated in Technology at 1.6% of assets, down from 2% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, Jeff Yass opened a new position in Brookfield Asset Management worth $86M.
- Jeff Yass's largest Q1 2025 buy was Brookfield Asset Management: 1,775,684 shares worth $86M.
- Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $4.05B increase.
- Jeff Yass's biggest Q1 2025 reduction was Invesco QQQ Trust, cutting an estimated $1.25B.
- Jeff Yass fully exited Inari Medical, Inc. Common Stock in Q1 2025, selling an estimated $24M.
- Jeff Yass's ten largest holdings make up 28% of its $586B portfolio in Q1 2025.
- Jeff Yass opened 1,775 new positions and closed 1,483 in Q1 2025.
- Jeff Yass's portfolio value fell 12% quarter-over-quarter to $586B.
Based on Susquehanna International Group's 13F filing for Q1 2025, filed 14 May 2025.